Canada’s National Advisory Committee on Immunization is giving the Oxford-AstraZeneca COVID-19 vaccine the green light to be used on adults who are 65 or older. (AP Photo/Frank Augstein)

Canada’s National Advisory Committee on Immunization is giving the Oxford-AstraZeneca COVID-19 vaccine the green light to be used on adults who are 65 or older. (AP Photo/Frank Augstein)

How effective is the AstraZeneca COVID-19 vaccine? What Canadians need to know

Here’s what we know about the AstraZeneca vaccine:

Canada’s National Advisory Committee on Immunization is giving the Oxford-AstraZeneca COVID-19 vaccine the green light to be used on adults who are 65 or older.

That decision comes two weeks after NACI said there wasn’t enough evidence from clinical trials to show whether the AstraZeneca jab was as effective in older populations.

Health experts who disagreed with NACI’s March 1 decision pointed to real-world data suggesting the shot was safe and effective among the elderly. Countries like France and Germany, who previously said they wouldn’t offer AstraZeneca to those over 65, recently reversed their decisions.

Those countries, and several others around Europe, have since paused the use of AstraZeneca for another reason — reports of blood clots among some recipients after receiving the jab. European regulators say there’s no evidence the shot is to blame, however.

AstraZeneca’s vaccine was the third to be approved by Health Canada, joining Pfizer-BioNTech and Moderna in late February. Canada has since authorized a fourth vaccine by Johnson & Johnson.

Here’s what we know about the AstraZeneca vaccine:

HOW EFFECTIVE IS IT?

Data from clinical trials showed AstraZeneca was 62 per cent effective in preventing COVID infections, but it also prevented death and hospitalization in all participants who got the virus after receiving the vaccine.

Efficacy was a major talking point when AstraZeneca was first approved, with some comparing it to the 95 per cent efficacy shown in mRNA vaccine trials from Pfizer and Moderna. But experts have stressed that all the authorized vaccines offer excellent protection against severe disease.

Dr. Zain Chagla, an infectious disease expert with McMaster University, says when dosing regimens are factored in, AstraZeneca’s efficacy rises to “70 to 80 per cent by the second dose, which is comparable to Pfizer, Moderna and Johnson & Johnson.”

Real-world data is emerging that may also suggest the efficacy of AstraZeneca’s vaccine increases over a longer time interval between the first and second shot. Clinical trials used a four-week span between doses but some countries have been delaying second doses by several weeks.

DOES IT WORK AGAINST THE NEW VARIANTS?

AstraZeneca’s vaccine had some promising data last month suggesting it works against the variant first detected in the U.K. Findings based on swabs taken from around 500 volunteers in trials between October and January showed a 74.6 per cent efficacy rate against that variant.

A group of experts on immunization working with the World Health Organization recommended the use of AstraZeneca’s vaccine in February, even in countries where variants have emerged as dominant.

That guidance came after a small study in South Africa suggested AstraZeneca’s vaccine was only minimally effective against the variant first detected there, causing the country to halt use of the product.

WHAT ABOUT THE BLOOD CLOT ISSUE?

A number of AstraZeneca recipients in Europe have reported blood clots after getting the jab, casting doubt on its safety. But a European Union medicine regulator said Tuesday there was “no indication” that AstraZeneca’s vaccines are causing the reported clots.

Dr. Lynora Saxinger, an infectious disease specialist with the University of Alberta, says a blood clot, or a pulmonary embolism, is “an incredibly common thing.”

Saxinger said she would need to see more information about the blood clots that are being reported, such as how old the recipients are. But numbers of those reporting the clots should also be seen in the context of how many people get the vaccine and don’t report that side effect, she added.

“We did not see any signal of (blood clots) in the trials of the vaccine, which had tens of thousands of people in them,” Saxinger said.

Chagla says data suggests the number of those reporting blood clots is well within the normal range experts would expect to see in a given population, meaning they may have happened in those people whether they got the vaccine or not.

AstraZeneca said over the weekend that a review of 17 million patients who received the shot in Europe and the U.K. shows no elevated risk of blood clotting.

Prime Minister Justin Trudeau offered reassurances on the safety of the AstraZeneca vaccine on Monday, saying Health Canada regulators are constantly analyzing all the available information and have guaranteed that the inoculations approved in Canada are safe for use.

HOW DOES THE VACCINE WORK?

Unlike Pfizer-BioNTech and Moderna, which use messenger RNA (mRNA), the AstraZeneca vaccine is a non-replicating viral vector, using a weakened chimpanzee cold virus as a vessel.

Scientists stripped the genes from that virus, which isn’t harmful to humans, and replaced them with the spike protein gene for SARS-CoV-2.

Once injected, the vaccine shows our bodies how to produce the immune response needed to ward off future infections from the COVID-19 virus.

Some may see outward signs of an immediate immune response to the vaccine — the body’s way of preparing for what it perceives as an attack by the virus. This can cause side effects usually seen with other vaccines, including pain at the injection site, redness, swelling and even fever, but experts say that means the vaccine is working.

Coronavirusvaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Cheryl Dill visits the PQB News/VI Free Daily studio. (Peter McCully photo)
PQBeat: Talking jobs, tourism and business with Cheryl Dill in Parksville

Podcast: COVID-19 has far-reaching impacts on Vancouver Island

(File photo)
PQB crime report: Vandals strike in Parksville, prowler lurks in Nanoose Bay

Oceanside RCMP receive 276 complaints in one-week period

Pub patio in Victoria reopens with widely spaced tables, June 2020. Restaurants and pubs across are restricted to take-out and patio service only until May 25 at the earliest. (Tom Fletcher/Black Press)
B.C. extends COVID-19 indoor dining, group fitness ban until May 25

Don’t travel outside your region, Dr. Bonnie Henry warns

Carver Ken Sheen had almost finished work on a large cowboy carving commissioned by the City of Williams Lake to replace the original overlooking the Stampede Grounds when fire broke out Friday, April 18 at his property between Williams Lake and Quesnel. (Pine River Carving Facebook photos)
Cow boss statue destined for Williams Lake Stampede Grounds goes up in flames

Carver Ken Sheen lost the statue, all his tools and his shop in the blaze

B.C. Labour Minister Harry Bains. (Hansard TV)
B.C. moves to protect employee pay for COVID-19 vaccination

Most won’t need to take time off work, labour minister says

Orca 1
Orcas: Our Shared Future finally surfaces at Royal B.C. Museum

Museum dives into the world of the killer whale as delayed feature exhibition now open

New figures show Canadian housing prices outpacing those in other developed countries. (Black Press Media file photo)
Canadian housing prices fastest rising in the world

Relative to 2000, housing prices have risen by a factor of more than 2.5

Polystyrene has been outlawed as a take-out option for restaurants in Tofino and Ucluelet. (Black Press Media file photo)
Styrofoam done as a takeout option on Island’s Pacific Rim

Tofino and Ucluelet ban polystyrene take-out containers

Most Read